Oncodesign is currently owned by Edmond de Rothschild Private Equity (France), through Edmond de Rothschild Equity Strategies IV, since 2022.

When did Edmond de Rothschild Private Equity (France) acquire Oncodesign?

Edmond de Rothschild Private Equity (France) acquired Oncodesign in 2022 (active for 4 years).

Home/Companies/Healthcare/Oncodesign

Oncodesign

Healthcare·

France·Active·4yr hold

Oncodesign is a healthcare company, headquartered in France.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Most recent investor

Edmond de Rothschild Private Equity (France)

4 ownership periods

Key facts

HQFrance

SectorHealthcare

French CRO services-to-biotechs platform EdR Equity Strategies IV advised by Elyan Partners acquired majority stake October 2022 plus…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Edmond de Rothschild Equity Strategies IV

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings